SCHEMBL10698893

SCHEMBL10698893

O=C(O)c1c(N2CCNCC2)[nH]c2ccccc2c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 5/20 0.45
HPGD P15428 3/20 0.45
GAA P10253 3/20 0.45
GLA P06280 2/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PBRM1 Q86U86 1/20 0.43
NPC1 O15118 1/20 0.42
JAK2 O60674 1/20 0.42
RAB9A P51151 1/20 0.42
PAX8 Q06710 1/20 0.42
HTR6 P50406 6/20 0.42
HSD17B10 Q99714 3/20 0.41
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10764117 0.86 KDM4E (0.47) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL10433439 0.85 GAA (0.47) KDM4ETDP1ALDH1A1HPGDGAA
Hydrochloric Acid SCHEMBL10765883 0.85 KDM4E (0.46) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL6831687 0.83 HRH4 (0.41) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL8699829 0.81 ESR1 (0.46) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL10572503 0.78 KDM4E (0.57) KDM4ETDP1ALDH1A1HPGDNPC1
SCHEMBL10514956 0.76 HTR2C (0.48) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL6626014 0.74 KDM4E (0.38) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL7214494 0.74 KDM4E (0.43) KDM4ETDP1ALDH1A1HPGDGAA
SCHEMBL6280799 0.71 KDM4E (0.59) KDM4ETDP1ALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0266576-A2 1-Tert-alkyl-substituted naphthyridine and quinoline carboxylic acids as antibacterial agents Bristol-Myers Squibb Company (US) 1988-05-11 EP disclosed